Comment on Fauconnier, A. Phage Therapy Regulation: From Night to Dawn

Comment on Fauconnier, A. Phage Therapy Regulation: From Night to Dawn

With most interest we read the contribution made by Fauconnier on phage therapy regulation [...]

Bibliographic Details
Main Authors:	Eric Pelfrene, Zigmars Sebris, Marco Cavaleri
Format:	Article
Language:	English
Published:	MDPI AG 2019-08-01
Series:	Viruses
Subjects:	antimicrobial resistance bacteriophage personalised medicines phage therapy pharmaceutical legislation regulatory framework
Online Access:	https://www.mdpi.com/1999-4915/11/9/771

Similar Items

The Medicinal Phage—Regulatory Roadmap for Phage Therapy under EU Pharmaceutical Legislation
by: Timo Faltus
Published: (2024-03-01)

Phage Therapy Regulation: From Night to Dawn
by: Alan Fauconnier
Published: (2019-04-01)

Adaptive Phage Therapy for the Prevention of Recurrent Nosocomial Pneumonia: Novel Protocol Description and Case Series
by: Fedor Zurabov, et al.
Published: (2023-12-01)

Phage Therapy in Germany—Update 2023
by: Christian Willy, et al.
Published: (2023-02-01)

The Age of Phage: Friend or Foe in the New Dawn of Therapeutic and Biocontrol Applications?
by: Ahmad Y. Hassan, et al.
Published: (2021-02-01)

Editorial: Pharmacological and Immunological Action of Bacteriophages: Focus on Phage Therapy
by: Mayank Gangwar, et al.
Published: (2022-04-01)

Phage Therapy—Challenges, Opportunities and Future Prospects
by: Beata Zalewska-Piątek
Published: (2023-11-01)

The Israeli Phage Bank (IPB)
by: Ortal Yerushalmy, et al.
Published: (2020-05-01)

Fitness Trade-Offs between Phage and Antibiotic Sensitivity in Phage-Resistant Variants: Molecular Action and Insights into Clinical Applications for Phage Therapy
by: Jumpei Fujiki, et al.
Published: (2023-10-01)

What’s in a Name? An Overview of the Proliferating Nomenclature in the Field of Phage Lysins
by: Roberto Vázquez, et al.
Published: (2023-08-01)

Editorial: Standards in personalized phage therapy: from phage collection to phage production
by: Saija Kiljunen, et al.
Published: (2024-03-01)

Comparison of Staphylococcus Phage K with Close Phage Relatives Commonly Employed in Phage Therapeutics
by: Jude Ajuebor, et al.
Published: (2018-04-01)

Towards Inhaled Phage Therapy in Western Europe
by: Sandra-Maria Wienhold, et al.
Published: (2019-03-01)

The Magistral Phage
by: Jean-Paul Pirnay, et al.
Published: (2018-02-01)

Phage Therapy
by: Joana Azeredo, et al.
Published: (2021-12-01)

Phage display for the detection, analysis, disinfection, and prevention of Staphylococcus aureus
by: Lei Tian, et al.
Published: (2022-12-01)

Isolation and Characterization of a Novel <i>Vibrio natriegens</i>—Infecting Phage and Its Potential Therapeutic Application in Abalone Aquaculture
by: Xuejing Li, et al.
Published: (2022-11-01)

Phage Biocontrol of Enteropathogenic and Shiga Toxin-Producing Escherichia coli in Meat Products
by: David Damian Tomat, et al.
Published: (2013-06-01)

Animal Models of Phage Therapy
by: Samuel Penziner, et al.
Published: (2021-01-01)

λ Recombineering Used to Engineer the Genome of Phage T7
by: Jordan D. Jensen, et al.
Published: (2020-11-01)

Isolation and Characterization of <i>Salmonella</i> Jumbo-Phage pSal-SNUABM-04
by: Jun Kwon, et al.
Published: (2020-12-01)

Editorial: Phage-bacteria interplay: Future therapeutic approaches against antibiotic resistant bacteria
by: Cecilia A. Silva-Valenzuela, et al.
Published: (2022-12-01)

Aspects of Phage-Based Vaccines for Protein and Epitope Immunization
by: Marco Palma
Published: (2023-02-01)

Grand Challenges in Phage Biology
by: Sangryeol Ryu, et al.
Published: (2021-07-01)

Bacteriophages, phage endolysins and antimicrobial peptides – the possibilities for their common use to combat infections and in the design of new drugs
by: Tomasz Mirski, et al.
Published: (2019-06-01)

1st German Phage Symposium—Conference Report
by: Irene Huber, et al.
Published: (2018-03-01)

Stability of magistral phage preparations before therapeutic application in patients with chronic rhinosinusitis, sepsis, pulmonary, and musculoskeletal infections
by: Saartje Uyttebroek, et al.
Published: (2023-12-01)

Identification and impact on Pseudomonas aeruginosa virulence of mutations conferring resistance to a phage cocktail for phage therapy
by: Francesca Forti, et al.
Published: (2023-12-01)

The Future of Clinical Phage Therapy in the United Kingdom
by: Joshua D. Jones, et al.
Published: (2023-03-01)

Defeating Antibiotic- and Phage-Resistant Enterococcus faecalis Using a Phage Cocktail in Vitro and in a Clot Model
by: Leron Khalifa, et al.
Published: (2018-02-01)

Bacteriophage-Mediated Control of Biofilm: A Promising New Dawn for the Future
by: Cheng Chang, et al.
Published: (2022-04-01)

Phages for Biofilm Removal
by: Celia Ferriol-González, et al.
Published: (2020-05-01)

Phage-host interplay: examples from tailed phages and Gram-negative bacterial pathogens
by: Soraya eChaturongakul, et al.
Published: (2014-08-01)

Characterization and genomic study of EJP2, a novel jumbo phage targeting antimicrobial resistant Escherichia coli
by: Dohyeong Jo, et al.
Published: (2023-05-01)

Prospects for the creation of liposomal antimicrobials based on phages
by: Pylypenko D. М., et al.
Published: (2023-10-01)

Encapsulation of specific Salmonella Enteritidis phage f3αSE on alginate-spheres as a method for protection and dosification
by: María José Soto, et al.
Published: (2018-01-01)

Designing phage cocktails to combat the emergence of bacteriophage-resistant mutants in multidrug-resistant Klebsiella pneumoniae
by: Seongjun Yoo, et al.
Published: (2024-01-01)

Biological foundations of successful bacteriophage therapy
by: Carola Venturini, et al.
Published: (2022-07-01)

Characterization of Novel Broad-Host-Range Bacteriophage DLP3 Specific to Stenotrophomonas maltophilia as a Potential Therapeutic Agent
by: Danielle L. Peters, et al.
Published: (2020-06-01)

Pharmacological limitations of phage therapy
by: Anders S. Nilsson
Published: (2019-10-01)